 |
The Journal of Neuroscience, October 27, 2004, 24(43):9531-9540; doi:10.1523/JNEUROSCI.3085-04.2004
Previous Article | Next Article 
Neurobiology of Disease
Human Immunodeficiency Virus Type 1 gp120 Induces Apoptosis in Human Primary Neurons through Redox-Regulated Activation of Neutral Sphingomyelinase
Arundhati Jana and
Kalipada Pahan
Section of Neuroscience, Department of Oral Biology, University of Nebraska Medical Center, Lincoln, Nebraska 68583
Human immunodeficiency virus type 1 (HIV-1) infection is known to cause disorders of the CNS, including HIV-associated dementia (HAD). HIV-1 coat protein gp120 (glycoprotein 120) induces neuronal apoptosis and has been implicated in the pathogenesis of HAD. However, the mechanism by which gp120 causes neuronal apoptosis is poorly understood. The present study underlines the importance of gp120 in inducing the production of ceramide, an important inducer of apoptosis, in human primary neurons. gp120 induced the activation of sphingomyelinases (primarily the neutral one) and the production of ceramide in primary neurons. Antisense knockdown of neutral (NSMase) but not acidic (ASMase) sphingomyelinase markedly inhibited gp120-mediated apoptosis and cell death of primary neurons, suggesting that the activation of NSMase but not ASMase plays an important role in gp120-mediated neuronal apoptosis. Similarly, the HIV-1 regulatory protein Tat also induced neuronal cell death via NSMase. Furthermore, gp120-induced production of ceramide was redox sensitive, because reactive oxygen species were involved in the activation of NSMase but not ASMase. gp120 coupled CXCR4 (CXC chemokine receptor 4) to induce NADPH oxidase-mediated production of superoxide radicals in neurons, which was involved in the activation of NSMase but not ASMase. These studies suggest that gp120 may induce neuronal apoptosis in the CNS of HAD patients through the CXCR4-NADPH oxidase-superoxide-NSMase-ceramide pathway.
Key words: HIV-1 gp120; ceramide; sphingomyelinases; NADPH oxidase; neurons; apoptosis
Received April 29, 2004;
revised August 31, 2004;
accepted September 2, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
V.V.R. Bandaru, J. C. McArthur, N. Sacktor, R. G. Cutler, E. L. Knapp, M. P. Mattson, and N. J. Haughey
Associative and predictive biomarkers of dementia in HIV-1-infected patients
Neurology,
May 1, 2007;
68(18):
1481 - 1487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Ng and D. E. Griffin
Acid Sphingomyelinase Deficiency Increases Susceptibility to Fatal Alphavirus Encephalomyelitis
J. Virol.,
November 15, 2006;
80(22):
10989 - 10999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Roy, Y. K. Fung, X. Liu, and K. Pahan
Up-regulation of Microglial CD11b Expression by Nitric Oxide
J. Biol. Chem.,
May 26, 2006;
281(21):
14971 - 14980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Brahmachari, Y. K. Fung, and K. Pahan
Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide.
J. Neurosci.,
May 3, 2006;
26(18):
4930 - 4939.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|